US drafts plan to fight feared Alzheimer's disease
February 22, 2012 By LAURAN NEERGAARD , AP Medical Writer in Alzheimer's disease & dementia
(AP) -- The Obama administration declared Alzheimer's "one of the most feared health conditions" on Wednesday as it issued a draft of a new national strategy to fight the ominous rise in this mind-destroying disease.
More than 5 million Americans already have Alzheimer's or similar dementias, a toll expected to reach up to 16 million by 2050 - along with skyrocketing medical and nursing home bills - because the population is aging so rapidly.
The government's top goal: Find some effective ways to treat Alzheimer's by 2025. That's an ambitious quest. Today's treatments only temporarily ease symptoms. Scientists know that Alzheimer's brews for years before symptoms appear, but work to find better medications or at least stall the disease's emergence has been frustratingly slow.
Whether scientists can meet that deadline or not, the draft of the first National Alzheimer's Plan also makes clear that overwhelmed families need help right away to care for affected loved ones.
Moreover, as many as half of today's Alzheimer's sufferers haven't been formally diagnosed, and the draft in part blames stigma and misinformation.
Among the draft's planned steps:
-Conduct a major public awareness campaign to help people know the early warning signs of Alzheimer's and what to do.
-Educate doctors and other health workers about how to recognize Alzheimer's, what medications are available now that can help with the disease's symptoms, and what social services may help families to cope.
-Improve early detection, in part by determining the best cognitive screening to offer during Medicare's new annual wellness visit.
-Improve training of caregivers, so they know what resources are available and how to handle common behavior problems of dementia. Research shows that caregivers given such training are able to keep their loved ones at home for far longer.
-Study how to address the health needs of stressed and isolated caregivers.
Then there's the goal of better treatments. The National Institutes of Health spends about $450 million a year on dementia research. Earlier this month, the Obama administration announced it would add an extra $50 million to that tab this year, and seek $80 million more to spend on Alzheimer's research in 2013.
It plans to spend about $26 million on some of the plan's other provisions.
For comparison, the government spends nearly $3 billion on AIDS research; about 1.1 million Americans are living with the AIDS virus.
Wednesday's draft is open for public comment through March, and the government's Alzheimer's advisory council is sure to make changes before a final strategy is issued later this year. But some of the work isn't waiting: The NIH, for example, is bringing together top Alzheimer's scientists in May to discuss the most promising leads for better treatment.
Some members of that advisory council called the draft a good first step.
"They've covered the right topics. What is needed now is more detail," said Alzheimer's Association President Harry Johns. "There's real recognition at this point that Alzheimer's is devastating for not only the individual but for the families and caregivers."
"Today, with the strong commitment of federal leaders and louder outcry from the public, the urgency of the Alzheimer's disease crisis is being recognized and acted upon," said Eric J. Hall, president of the Alzheimer's Foundation of America.
More information: Alzheimer's plan: http://aspe.hhs.gov/daltcp/napa/(hash)DraftNatlPlan
©2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
-
US wants effective Alzheimer's treatment by 2025
Jan 17, 2012 |
not rated yet |
0
-
Obama to seek more Alzheimer's research money
Feb 07, 2012 |
not rated yet |
0
-
Families urge action as US drafts Alzheimer's plan
Sep 12, 2011 |
not rated yet |
0
-
Alzheimer's disease to quadruple worldwide by 2050
Jun 10, 2007 |
not rated yet |
0
-
Alzheimer's cost triple that of other elderly
Mar 24, 2009 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
The idea behind a reverse shock
2 hours ago
-
Guass's Law for a charge distribution
2 hours ago
-
Noise dependence
3 hours ago
-
siphon and bernouli theorum
4 hours ago
-
Hot gas expansion rate into outer space
4 hours ago
-
Magnetic field lines through copper
9 hours ago
- More from Physics Forums - Classical Physics
More news stories
A new strategy required in the search for Alzheimer's drugs?
In the search for medication against Alzheimer's disease, scientists have focused – among other factors – on drugs that can break down Amyloid beta (A-beta). After all, it is the accumulation of A-beta that causes the ...
Alzheimer's disease & dementia
May 24, 2013 |
not rated yet |
0
Alzheimer's disease, the soft target of the euthanasia debate
(Medical Xpress)—The way Alzheimer's disease is portrayed by advocacy groups and the media is having undue influence on the euthanasia debate, according to a Deakin University nursing ethics professor.
Alzheimer's disease & dementia
May 24, 2013 |
not rated yet |
2
Scientists discover cinnamon compounds' potential ability to prevent Alzheimer's
Cinnamon: Can the red-brown spice with the unmistakable fragrance and variety of uses offer an important benefit? The common baking spice might hold the key to delaying the onset of –– or warding off ...
Alzheimer's disease & dementia
May 23, 2013 |
5 / 5 (5) |
0
|
Drug reverses Alzheimer's disease deficits in mice, research confirms
An anti-cancer drug reverses memory deficits in an Alzheimer's disease mouse model, University of Pittsburgh Graduate School of Public Health researchers confirm in the journal Science.
Alzheimer's disease & dementia
May 23, 2013 |
not rated yet |
0
|
Multiple research teams unable to confirm high-profile Alzheimer's study
Teams of highly respected Alzheimer's researchers failed to replicate what appeared to be breakthrough results for the treatment of this brain disease when they were published last year in the journal Science.
Alzheimer's disease & dementia
May 23, 2013 |
3 / 5 (2) |
3
|
Seniors more likely to crash when driving with pet, study finds
(HealthDay)—Animals make great companions for senior citizens, but elderly people who always drive with a pet in the car are far more likely to crash than those who never drive with a pet, researchers have ...
First drug to improve heart failure mortality in over a decade
Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...
Heart failure accelerates male 'menopause'
Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...
Death highest in heart failure patients admitted in January, on Friday, and overnight
Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...
Feds fight morning-after pill age ruling in NY
(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...
Driving and hands-free talking lead to spike in errors, study shows
Talking on a hands-free device while behind the wheel can lead to a sharp increase in errors that could imperil other drivers on the road, according to new research from the University of Alberta.